| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
11 companies
Gsk Plc serves as a 10% Owner at LYEL and has filed Form 4s across 11 companies. Across recent SEC filings that breaks down to 14 buys and 5 sells. Those positions are worth an estimated $568.5M at current prices.
Historically, Gsk Plc's trades have earned a below-average insider score of 42/100 across 5 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -3.0%.
The biggest single holding is WVE (~$346.7M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 7,561,930 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | WVE Wave Life Sciences Ltd. | 10% Owner | Buy | 1,470,000 | $19.00 | $27,930,000.00 | +8.8% | - | - | |
| Sep 27, 2024 | WVE Wave Life Sciences Ltd. | 10% Owner | Buy | 2,791,930 | $8.00 | $22,335,440.00 | +20.0% | - | - | |
| Dec 7, 2023 | WVE Wave Life Sciences Ltd. | 10% Owner | Buy | 3,300,000 | $5.00 | $16,500,000.00 | +30.9% | - | - | |
| Jul 2, 2021 | CVRX Cvrx, Inc. | 10% Owner | Buy | 275,000 | $18.00 | $4,950,000.00 | +37.5% | -35.0% | -76.0% | |
| May 20, 2021 | INVA Innoviva, Inc. | 10% Owner | Sell | 32,005,260 | $12.25 | $392,064,435.00 | -100% | +21.2% | +22.3% | |
| Jul 15, 2020 | BCYC Bicycle Therapeutics Plc | 10% Owner | Sell | 4,744 | $19.36 | $91,825.59 | -0.2% | - | - | |
| Jul 14, 2020 | NKTX Nkarta, Inc. | Director, 10% Owner | Buy | 833,333 | $18.00 | $14,999,994.00 | +36.0% | - | - | |
| May 20, 2020 | PGNY Progyny, Inc. | 10% Owner | Sell | 4,000,000 | $25.75 | $103,000,000.00 | -39.1% | - | - | |
| May 28, 2019 | BCYC Bicycle Therapeutics Plc | Director, 10% Owner | Buy | 385,714 | $14.00 | $5,399,996.00 | +25.2% | - | - | |
| Jul 17, 2018 | SPRO Spero Therapeutics, Inc. | 10% Owner | Buy | 80,000 | $12.50 | $1,000,000.00 | +4.3% | - | - |